Cargando…
Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity
A major advantage of DNA vaccination is the ability to induce both humoral and cellular immune responses. DNA vaccines are currently used in veterinary medicine, but have not achieved widespread acceptance for use in humans due to their low immunogenicity in early clinical studies. However, recent c...
Autores principales: | Suschak, John J., Williams, James A., Schmaljohn, Connie S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718814/ https://www.ncbi.nlm.nih.gov/pubmed/28604157 http://dx.doi.org/10.1080/21645515.2017.1330236 |
Ejemplares similares
-
Nanoplasmid Vectors Co-expressing Innate Immune Agonists Enhance DNA Vaccines for Venezuelan Equine Encephalitis Virus and Ebola Virus
por: Suschak, John J., et al.
Publicado: (2020) -
An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice
por: Bounds, Callie E., et al.
Publicado: (2017) -
A CCHFV DNA vaccine protects against heterologous challenge and establishes GP38 as immunorelevant in mice
por: Suschak, John J., et al.
Publicado: (2021) -
Immunogenicity of a protective intradermal DNA vaccine against lassa virus in cynomolgus macaques
por: Jiang, Jingjing, et al.
Publicado: (2019) -
Cytolytic Perforin as an Adjuvant to Enhance the Immunogenicity of DNA Vaccines
por: Shrestha, Ashish C., et al.
Publicado: (2019)